Sales & Marketing News | pharmaphorum

News

FTC lawsuit against Amgen sends shiver through pharma

Rumours that the US financial regulator is planning to block Amgen’s $28 billion takeover of Horizon Therapeutics have turned out to be true, and the industry is now scram

News

PM Society announces new industry council and expands Board

The PM Society, which supports companies and individuals working in pharma marketing and healthcare communications, has created a new Industry Council and expanded its Board of Directors.

News

Reports say FTC is planning to block Amgen’s Horizon deal

Shares in Horizon Therapeutics have been in sharp decline after reports emerged that the US financial regulator is preparing a challenge to its $28 billion takeover by Amg

News

Astellas breaks new ground in menopause with Veozah

Astellas has become the first drugmaker to bring a drug in the neurokinin 3 (NK3) receptor antagonist class to the US market, after getting FDA approval of fezolinetant fo

News

SCOTUS won’t hear ‘skinny label’ lawsuit

The US Supreme Court has refused to look at the result of a federal lawsuit between GSK and Teva over so-called ‘skinny labels’ for generic drugs, despite a request from t

News

Babylon retreats from public listing as losses climb

Shares in Babylon Health were pummelled yesterday after it said it would go back into private hands and withdrew its financial forecasts for the year.

FTC lawsuit against Amgen sends shiver through pharma

PM Society announces new industry council and expands Board

Reports say FTC is planning to block Amgen’s Horizon deal

Astellas breaks new ground in menopause with Veozah

SCOTUS won’t hear ‘skinny label’ lawsuit

Babylon retreats from public listing as losses climb

Pfizer cues up vitiligo filing for Litfulo after phase 3 win

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks